Cytomedix to Host Third Quarter 2010 Financial Results Conference Call on Thursday, November 11, 2010
02 nov. 2010 08h59 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Showcase AutoloGel System at the 18th Annual Scientific Meeting of the International Society of Hair Restoration Surgery
20 oct. 2010 08h15 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 20, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Secures $13 Million in Committed Funding
08 oct. 2010 08h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Oral Presentation at the Academy of Spinal Cord Injury Professionals' Annual Meeting
23 sept. 2010 09h13 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Announces AutoloGel System Poster Presentation at the Symposium on Advanced Wound Care (SAWC) Fall 2010
23 sept. 2010 09h04 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix to Present at Rodman & Renshaw 12th Annual Global Investment Conference
07 sept. 2010 08h00 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports Second Quarter 2010 Financial Results
16 août 2010 17h27 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host Second Quarter 2010 Financial Results Conference Call on Tuesday, August 17, 2010
09 août 2010 10h05 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Cytomedix Appoints Patrick Vanek as Vice President of Operations
28 juil. 2010 10h47 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., July 28, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Positive Data From Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management
16 juin 2010 09h23 HE
|
Cytomedix, Inc.
ROCKVILLE, Md., June 16, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...